Brian A. King appointed as new CTP director by FDA

May.23.2022
Dr. Brian A.King is appointed as the new director of the Center for Tobacco Products by the FDA.

The United States Food and Drug Administration (FDA) has appointed Brian A. King as the new director of the Center for Tobacco Products (CTP).

 

After an intensive executive search, I have chosen Dr. Brian A. King to serve as the new director for the FDA's Center for Tobacco Products," wrote Robert Califf on Twitter. "Dr. King brings impressive expertise in tobacco prevention and control, and has over 10 years of experience working at the CDC, making him well-versed in the operations of the FDA.

 

King is the Deputy Director of Research Translation at the Smoking and Health Office (OSH) of the National Center for Chronic Disease Prevention and Health Promotion at the Centers for Disease Control and Prevention (CDC). In this role, he is responsible for providing scientific leadership and technical expertise to the federal lead agency CDC/OSH for comprehensive tobacco prevention and control efforts.

 

In 2010, King joined the Centers for Disease Control and Prevention as an Epidemic Intelligence Service officer. Prior to this, he worked at the Roswell Park Comprehensive Cancer Center in Buffalo, New York, as a research affiliate in cancer prevention and population sciences division. During his time at Roswell Park, his main research focused on tobacco prevention and control.

 

For the past 15 years, King has been dedicated to providing reliable scientific evidence to inform tobacco control policies, effectively communicating this information to key stakeholders including decision makers, media, and the general public. He has authored or co-authored over 200 peer-reviewed scientific articles on tobacco prevention and control, was the author of the Surgeon General's 50th anniversary report on smoking and health, and was the lead author for the Centers for Disease Control and Prevention's 2014 update to the evidence-based national guidelines for comprehensive tobacco control programs. King also served as a senior editor for the 2016 Surgeon General's report on youth and young adult e-cigarette use and the 2020 Surgeon General's report on quitting smoking. He was also a senior official for the CDC's emergency response to the 2019 outbreak of lung injury associated with e-cigarette or vaping product use.

 

King holds a Doctorate in Epidemiology and a Master's Degree in Public Health from the State University of New York at Buffalo.

 

Source: Tobacco Reporter.

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

French Lawmakers Move to Extend Plain Packaging Rules to Vaping Product
French Lawmakers Move to Extend Plain Packaging Rules to Vaping Product
French lawmakers Nicolas Thierry and Pierre Cazenave said on April 15 that they will file a cross-party bill to extend plain packaging requirements to vaping products. Under the proposal, unit packs and outer packaging for vaping products, including those without nicotine, would become neutral and standardized in the same way cigarette packs have been since 2017.
Apr.16 by 2FIRSTS.ai
Reuters Exclusive: FDA’s Fast-Track Review of Nicotine Pouches Slows Over Youth and New-User Concerns
Reuters Exclusive: FDA’s Fast-Track Review of Nicotine Pouches Slows Over Youth and New-User Concerns
Reuters reported on April 1 that several popular nicotine pouch products still have not been cleared for sale in the United States despite a fast-track review pilot run by the U.S. Food and Drug Administration. Three sources said FDA reviewers have taken a cautious approach because of potential risks to youth and other non-tobacco users, including the possibility of driving nicotine addiction among adults who do not already smoke.
Apr.02 by 2FIRSTS.ai
Philip Morris Limited Launches Delia to Expand IQOS Iluma Consumables Portfolio
Philip Morris Limited Launches Delia to Expand IQOS Iluma Consumables Portfolio
Philip Morris Limited has announced the launch of Delia, the latest addition to its portfolio of heated tobacco and zero-tobacco sticks exclusively compatible with the IQOS Iluma range.
Apr.03 by 2FIRSTS.ai
PMI U.S. Says Dothan Factory Closure Reflects Focus on Smoke-Free Business Strategy
PMI U.S. Says Dothan Factory Closure Reflects Focus on Smoke-Free Business Strategy
Philip Morris International U.S. (PMI U.S.) announced that it will close the Swedish Match cigar manufacturing facility on Columbia Highway in Dothan, Alabama. The company said the decision reflects its need to maintain focus on offering reduced-risk, FDA-authorized smoke-free products to legal-aged adult nicotine users in the United States to help them move away from combustible cigarettes.
Mar.30 by 2FIRSTS.ai
Ukrainian Prosecutors and Economic Security Bureau Dismantle Illegal Vape Liquid Network Worth About UAH 30 Million
Ukrainian Prosecutors and Economic Security Bureau Dismantle Illegal Vape Liquid Network Worth About UAH 30 Million
Ukraine’s Office of the Prosecutor General and the Bureau of Economic Security said they uncovered an illegal production and sales scheme for e-cigarette liquids that had been operating in Ukraine since 2023.
Apr.14 by 2FIRSTS.ai
France Bans Zyn and Other Nicotine Pouches, Violators Face Jail and Fines
France Bans Zyn and Other Nicotine Pouches, Violators Face Jail and Fines
France has officially banned nicotine pouches and other oral nicotine products, including Zyn. The new regulation classifies such products as “toxic substances” and imposes criminal penalties on their use, possession, purchase, and sale. Violators may face up to five years in prison and fines of up to €400,000 (approximately $436,600).
Regulations
May.25